GTP-binding Proteins Mediate Noradrenaline Effects on Calcium and Chloride Currents in Rat Portal Vein Myocytes
Overview
Authors
Affiliations
1. Membrane currents were recorded by a patch-clamp pipette technique in cultured cells from rat portal vein using the whole-cell mode. 2. Noradrenaline (NA, 10(-5) M) and phorbol-12,13-dibutyrate (PDBu, 10(-7) M) produced an increase in voltage-dependent inward current carried by barium (5 mM), but their effects were not additive. Calcium-activated chloride current was evoked by NA but not by PDBu. 3. The NA-induced increase in peak voltage-dependent inward current was inhibited by intracellular application of GDP-beta-S (10(-3) M) while the effect of PDBu was unchanged. GDP-beta-S blocked the NA-induced chloride current but had no effect on the caffeine-induced chloride current. 4. Inclusion of GTP-gamma-S (10(-5)-10(-4) M) in the pipette solution increased the voltage-dependent inward current and inhibited the NA- or PDBu-induced increase in peak current. GTP-gamma-S potentiated the effect of NA on calcium-activated chloride current. At higher concentrations (10(-3) M), GTP-gamma-S activated the chloride current and prevented the effects of NA or caffeine on this current. 5. The combination of 10(-5) M-aluminium chloride and 10(-2) M-sodium fluoride had an effect similar to that of high concentrations of GTP-gamma-S on both inward current and calcium-activated chloride current. In contrast, arachidonic acid (10(-3) M) had no effect on calcium and chloride conductances activated by NA. 6. Cells responded normally to NA after pre-treatment for 4-30 h with 10 micrograms ml-1 pertussis toxin (PTx). 7. It is concluded that the stimulation of calcium and chloride conductances by NA is mediated through activation of a PTx-insensitive GTP-binding protein. This effect may involve activation of phospholipase C enzyme and production of both D-myo-inositol 1,4,5-trisphosphate which depletes calcium stores and diacylglycerol which activates protein kinase C.
Ozaki H, Yasuda K, Kim Y, Egawa M, Kanzaki H, Nakazawa H Br J Pharmacol. 2003; 140(7):1303-12.
PMID: 14581181 PMC: 1574139. DOI: 10.1038/sj.bjp.0705552.
Ghisdal P, Gomez J, Morel N J Physiol. 2000; 522 Pt 1:83-96.
PMID: 10618154 PMC: 2269741. DOI: 10.1111/j.1469-7793.2000.t01-3-00083.x.
McHugh D, Beech D J Physiol. 1997; 500 ( Pt 2):311-7.
PMID: 9147319 PMC: 1159385. DOI: 10.1113/jphysiol.1997.sp022022.
Hazama H, Nakajima T, Hamada E, Omata M, Kurachi Y J Physiol. 1996; 492 ( Pt 2):377-93.
PMID: 9019536 PMC: 1158834. DOI: 10.1113/jphysiol.1996.sp021315.
Ogata R, Inoue Y, Nakano H, Ito Y, Kitamura K Br J Pharmacol. 1996; 117(2):351-9.
PMID: 8789390 PMC: 1909250. DOI: 10.1111/j.1476-5381.1996.tb15198.x.